CTRI/2022/12/048573尚未招募4 期
A prospective, randomized, double-blind, placebo-controlled parallel-group clinical trial to evaluate the effects of a Bacillus coagulans-based product on protein digestion and utilization in gastro-intestinal tract
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subject has provided written and dated informed consent to participate in the study.
- •2.Subject is willing and able to comply with the protocol.
- •3.Healthy male/female of age 18-60 years.
- •4.Subject is in good health as determined by a health history questionnaire.
排除标准
- •1.Subject has a known allergy or sensitivity to any ingredient in the test product.
- •2.Subject on protein and/ or probiotic rich diet.
- •3.Subject has a history of alcohol or other drug abuse in the past year
研究者
相似试验
招募中
1 期
A clinical study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with cerebral palsy.Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)MedDRA version: 20.1Level: LLTClassification code: 10021740Term: Infantile cerebral palsy Class: 10010331MedDRA version: 20.0Level: LLTClassification code: 10041416Term: Spasticity Class: 10029205MedDRA version: 21.1Level: LLTClassification code: 10024132Term: Leg spasticity Class: 10029205CTIS2023-503420-19-00Merz Pharmaceuticals GmbH130
进行中（未招募）
1 期
Safety and efficacy study of the simultaneous treatment of upper facial lines (horizontal forehead lines, glabellar frown lines and crows feet) in subjects with moderate to severe upper facial lines.Moderate to severe upper facial lines(horizontal forehead lines, glabellar frown lines, and lateral canthal lines)MedDRA version: 20.0Level: LLTClassification code 10048042Term: WrinklesSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 21.1Level: LLTClassification code 10052609Term: Glabellar frown linesSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: LLTClassification code 10052611Term: Crow's feetSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 21.1Level: PTClassification code 10040954Term: Skin wrinklingSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: SOCClassification code 10040785Term: Skin and subcutaneous tissue disordersSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2019-004113-13-DEMerz Pharmaceuticals GmbH368
尚未招募
4 期
A clinical study to assess the effect of a Bacillus coagulans-based product on immunomodulation and stress levelsCTRI/2023/01/048720Abode Biotec India Private Limited
尚未招募
不适用
A Controlled parallel-group clinical study to assess the effect of a Bacillus coagulans-based product on immunomodulation and stress levelsCTRI/2020/07/026453Abode Biotec India Private Limited
进行中（未招募）
2 期
A study to test the effect of Pepzyme Pro on the digestion and absorption of Pea proteiCTRI/2021/10/037072Advanced Enzymes Ltd